학술논문
Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR)
Document Type
Academic Journal
Author
Gallo, G.; Di Saverio, S.; Clerico, G.; Sturiale, A .; Manigrasso, M.; Luc, A. Realis; Trompetto, M.; Sammarco, G.; Ferrari, Francesco; Carpino, Antonio; Sena, Giuseppe; Vescio, Giuseppina; Stratta, Emanuela; Luc, Alberto Realis; Clerico, Giuseppe; Trompetto, Mario; Tonello, Paolo; Cornaglia, Silvia; Greco, Vincenzo; Talarico, Carlo; Tutino, Roberta; Falco, Nicola; Venturelli, Paolina; Cocorullo, Gianfranco; Pietroletti, Renato; Rizza, Vinicio; Milito, Giovanni; Campanelli, Michela; Lisi, Giorgio; Brachitta, Salvatore; Cavallaro, Venera; Pecorella, Giuseppe; Turri, Bruno; Sasia, Diego; Giuffrida, Maria Carmela; Milone, Marco; Palma, Giovanni; Bianco, Vincenzo; Moggia, Elisabetta; Talamo, Giuseppina; Oggianu, Angelo; Pili, Michela; Palumbo, Alessio; Fazio, Marco; Aiello, Domenico; Bianco, Francesco; Bondurri, Andrea; Gallo, Gaetano; Torre, Marco; Macini, Stefano; Perinotti, Roberto; Serventi, Alberto; Fiorino, Marina
Source
BMC Surgery. October 22, 2020, Vol. 20 Issue 1
Subject
Language
English
ISSN
1471-2482
Abstract
Author(s): G. Gallo[sup.1,2], S. Di Saverio[sup.3], G. Clerico[sup.2], A . Sturiale[sup.4], M. Manigrasso[sup.5], A. Realis Luc[sup.2], M. Trompetto[sup.2], G. Sammarco[sup.6], Francesco Ferrari, Antonio Carpino, Giuseppe Sena, Giuseppina Vescio, Emanuela Stratta, [...]
Background Excisional haemorrhoidectomy is the gold standard technique in patients with III and IV degree haemorrhoidal disease (HD). However, it is associated with a significant rate of post-operative pain. The aim of our study was to evaluate the efficacy of mesoglycan in the post-operative period of patients who underwent open excisional diathermy haemorrhoidectomy (OEH). Methods This was a retrospective multicentre observational study. Three hundred ninety-eight patients from sixteen colorectal referral centres who underwent OEH for III and IV HD were enrolled. All patients were followed-up on the first post-operative day (T1) and after 1 week (T2), 3 weeks (T3) and 6 weeks (T4). BMI, habits, SF-12 questionnaire, VAS at rest (VASs), after defecation (VASd), and after anorectal digital examination (VASe), bleeding and thrombosis, time to surgical wound healing and autonomy were evaluated. Results In the mesoglycan group, post-operative thrombosis was significantly reduced at T2 (p < 0.05) and T3 (p < 0.005), and all patients experienced less post-operative pain at each time point (p < 0.001 except for VASe T4 p = 0.003). There were no significant differences between the two groups regarding the time to surgical wound healing or post-operative bleeding. There was an early recovery of autonomy in the mesoglycan group in all three follow-up periods (T2 p = 0.016; T3 p = 0.002; T4 p = 0.007). Conclusions The use of mesoglycan led to a significant reduction in post-operative thrombosis and pain with consequent early resumption of autonomy. Trial registration NCT04481698--Mesoglycan for Pain Control After Open Excisional HAEMOrrhoidectomy (MeHAEMO) https://clinicaltrials.gov/ct2/show/NCT04481698?term=Mesoglycan+for+Pain+Control+After+Open+Excisional+HAEMOrrhoidectomy+%28MeHAEMO%29&draw=2&rank=1 Keywords: Haemorrhoidal disease, Post-operative pain, Open excisional haemorrhoidectomy, Mesoglycan, Thrombosis, Mucocutaneous bridges
Background Excisional haemorrhoidectomy is the gold standard technique in patients with III and IV degree haemorrhoidal disease (HD). However, it is associated with a significant rate of post-operative pain. The aim of our study was to evaluate the efficacy of mesoglycan in the post-operative period of patients who underwent open excisional diathermy haemorrhoidectomy (OEH). Methods This was a retrospective multicentre observational study. Three hundred ninety-eight patients from sixteen colorectal referral centres who underwent OEH for III and IV HD were enrolled. All patients were followed-up on the first post-operative day (T1) and after 1 week (T2), 3 weeks (T3) and 6 weeks (T4). BMI, habits, SF-12 questionnaire, VAS at rest (VASs), after defecation (VASd), and after anorectal digital examination (VASe), bleeding and thrombosis, time to surgical wound healing and autonomy were evaluated. Results In the mesoglycan group, post-operative thrombosis was significantly reduced at T2 (p < 0.05) and T3 (p < 0.005), and all patients experienced less post-operative pain at each time point (p < 0.001 except for VASe T4 p = 0.003). There were no significant differences between the two groups regarding the time to surgical wound healing or post-operative bleeding. There was an early recovery of autonomy in the mesoglycan group in all three follow-up periods (T2 p = 0.016; T3 p = 0.002; T4 p = 0.007). Conclusions The use of mesoglycan led to a significant reduction in post-operative thrombosis and pain with consequent early resumption of autonomy. Trial registration NCT04481698--Mesoglycan for Pain Control After Open Excisional HAEMOrrhoidectomy (MeHAEMO) https://clinicaltrials.gov/ct2/show/NCT04481698?term=Mesoglycan+for+Pain+Control+After+Open+Excisional+HAEMOrrhoidectomy+%28MeHAEMO%29&draw=2&rank=1 Keywords: Haemorrhoidal disease, Post-operative pain, Open excisional haemorrhoidectomy, Mesoglycan, Thrombosis, Mucocutaneous bridges